|
rs2296147
|
|
Primary malignant neoplasm
|
|
0.050 |
GeneticVariation
|
BEFREE |
We evaluated the associations between six single nucleotide polymorphisms (SNPs) in XPG (rs1047768 T>C, rs2296147 T>C, rs2227869 G>C, rs2094258 C>T, rs751402 C>T, and rs873601 G>A) and cancer risk.
|
28416771 |
2017 |
|
rs2296147
|
|
Malignant Neoplasms
|
|
0.050 |
GeneticVariation
|
BEFREE |
We evaluated the associations between six single nucleotide polymorphisms (SNPs) in XPG (rs1047768 T>C, rs2296147 T>C, rs2227869 G>C, rs2094258 C>T, rs751402 C>T, and rs873601 G>A) and cancer risk.
|
28416771 |
2017 |
|
rs2296147
|
|
Malignant Neoplasms
|
|
0.050 |
GeneticVariation
|
BEFREE |
The moderate effects of rs751402 and rs2296147 polymorphism on cancer susceptibility might be highly dependent on cancer type and ethnicity, respectively.
|
28796034 |
2017 |
|
rs2296147
|
|
Primary malignant neoplasm
|
|
0.050 |
GeneticVariation
|
BEFREE |
The moderate effects of rs751402 and rs2296147 polymorphism on cancer susceptibility might be highly dependent on cancer type and ethnicity, respectively.
|
28796034 |
2017 |
|
rs2296147
|
|
Malignant Neoplasms
|
|
0.050 |
GeneticVariation
|
BEFREE |
This meta-analysis aimed to evaluate the reliable predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.
|
27588464 |
2016 |
|
rs2296147
|
|
Primary malignant neoplasm
|
|
0.050 |
GeneticVariation
|
BEFREE |
This meta-analysis aimed to evaluate the reliable predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.
|
27588464 |
2016 |
|
rs2296147
|
|
Primary malignant neoplasm
|
|
0.050 |
GeneticVariation
|
BEFREE |
The combination genotype of XPG rs2296147 T and CSB rs2228526 G allele had accumulative effect on the risk of this cancer, with an OR (95% CI) of 2.23(1.37-3.59).
|
24289586 |
2013 |
|
rs2296147
|
|
Malignant Neoplasms
|
|
0.050 |
GeneticVariation
|
BEFREE |
The combination genotype of XPG rs2296147 T and CSB rs2228526 G allele had accumulative effect on the risk of this cancer, with an OR (95% CI) of 2.23(1.37-3.59).
|
24289586 |
2013 |
|
rs2296147
|
|
Malignant Neoplasms
|
|
0.050 |
GeneticVariation
|
BEFREE |
Our results showed that rs751402 were associated with increased GC risk (AA vs. GG: OR=1.99, 95%CI: 1.20-3.31, P=0.008; AG+AA vs. GG: OR=1.41, 95%CI: 1.07-1.86, P=0.016), and rs2296147 was also associated with increased cancer risk (CC vs. TT: OR=2.17, 95%CI: 1.04-4.54, P=0.039; CC vs. CT+TT: OR=2.26, 95%CI: 1.09-4.69, P=0.028).
|
22982416 |
2012 |
|
rs2296147
|
|
Primary malignant neoplasm
|
|
0.050 |
GeneticVariation
|
BEFREE |
Our results showed that rs751402 were associated with increased GC risk (AA vs. GG: OR=1.99, 95%CI: 1.20-3.31, P=0.008; AG+AA vs. GG: OR=1.41, 95%CI: 1.07-1.86, P=0.016), and rs2296147 was also associated with increased cancer risk (CC vs. TT: OR=2.17, 95%CI: 1.04-4.54, P=0.039; CC vs. CT+TT: OR=2.26, 95%CI: 1.09-4.69, P=0.028).
|
22982416 |
2012 |
|
rs2296147
|
|
Xeroderma pigmentosum, group G
|
|
0.040 |
GeneticVariation
|
BEFREE |
Odds ratio (OR) and 95% confidence interval (CI) were used to assess the association between XPG polymorphisms (rs751402, rs873601, and rs2296147) and cancer risk.
|
28796034 |
2017 |
|
rs2296147
|
|
Xeroderma pigmentosum, group G
|
|
0.040 |
GeneticVariation
|
BEFREE |
We evaluated the associations between six single nucleotide polymorphisms (SNPs) in XPG (rs1047768 T>C, rs2296147 T>C, rs2227869 G>C, rs2094258 C>T, rs751402 C>T, and rs873601 G>A) and cancer risk.
|
28416771 |
2017 |
|
rs2296147
|
|
Xeroderma pigmentosum, group G
|
|
0.040 |
GeneticVariation
|
BEFREE |
XPG rs2296147 polymorphism could be predictive of unfavorable prognosis of CRC patients.
|
26887052 |
2016 |
|
rs2296147
|
|
Xeroderma pigmentosum, group G
|
|
0.040 |
GeneticVariation
|
BEFREE |
The XPG rs2296147T>C polymorphism might be a predictive factor of prognosis in cancers patients and contribute to individual treatment in the future.
|
27588464 |
2016 |
|
rs2296147
|
|
Stomach Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
None of the examined loci were statistically associated with GC risk, although rs2296147 was marginally associated with GC risk (<i>P</i> = 0.050).
|
31558863 |
2019 |
|
rs2296147
|
|
Malignant neoplasm of stomach
|
|
0.030 |
GeneticVariation
|
BEFREE |
None of the examined loci were statistically associated with GC risk, although rs2296147 was marginally associated with GC risk (<i>P</i> = 0.050).
|
31558863 |
2019 |
|
rs2296147
|
|
Malignant neoplasm of stomach
|
|
0.030 |
GeneticVariation
|
BEFREE |
We performed this hospital-based case-control study to evaluate the association of four potentially functional XPG polymorphisms (rs2094258 C>T, rs751402 C>T, rs2296147 T>C and rs873601G>A) with stomach cancer susceptibility.
|
26820236 |
2016 |
|
rs2296147
|
|
Stomach Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
We performed this hospital-based case-control study to evaluate the association of four potentially functional XPG polymorphisms (rs2094258 C>T, rs751402 C>T, rs2296147 T>C and rs873601G>A) with stomach cancer susceptibility.
|
26820236 |
2016 |
|
rs2296147
|
|
Stomach Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Genetic effects on increased GC risk seemed to be enhanced by Helicobacter pylori infection, smoking and alcohol drinking, with corresponding adjusted ORs of 4.57, 2.42 and 2.50 for the rs751402 AG/AA variants, and of 5.32, 3.20 and 6.87 for the rs2296147 CC variant, but their interaction effects on GC risk didn't reach statistically significance.
|
22982416 |
2012 |
|
rs2296147
|
|
Malignant neoplasm of stomach
|
|
0.030 |
GeneticVariation
|
BEFREE |
Genetic effects on increased GC risk seemed to be enhanced by Helicobacter pylori infection, smoking and alcohol drinking, with corresponding adjusted ORs of 4.57, 2.42 and 2.50 for the rs751402 AG/AA variants, and of 5.32, 3.20 and 6.87 for the rs2296147 CC variant, but their interaction effects on GC risk didn't reach statistically significance.
|
22982416 |
2012 |
|
rs2296147
|
|
Non-Small Cell Lung Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
In the Cox proportional hazard model, patients carrying the rs2296147 TT genotype and the T allele had a significantly reduced risk of developing progressive disease or dying from NSCLC.
|
25729984 |
2015 |
|
rs2296147
|
|
Malignant neoplasm of prostate
|
|
0.020 |
GeneticVariation
|
BEFREE |
In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.
|
24615090 |
2014 |
|
rs2296147
|
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.
|
24615090 |
2014 |
|
rs2296147
|
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.
|
24289586 |
2013 |
|
rs2296147
|
|
Malignant neoplasm of prostate
|
|
0.020 |
GeneticVariation
|
BEFREE |
Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.
|
24289586 |
2013 |